Sunday, October 25, 2020

Covid-19 Vaccine: Second AstraZeneca Volunteer Reportedly Suffers Rare Neurological Condition – Veterans Today

Must Read

Black passenger arrested in viral TikTok after not showing ID had active warrants, police say

A viral TikTok showing a Black man being aggressively pulled out of the passenger seat after refusing to show...

Caught: Fake scientists giving false COVID death rates, Italy at over 12 percent, US near 4% – Veterans Today

By Gordon Duff, Senior EditorSome areas of the country, the US, are having low COVID death rates, we don’t...

The devil makes the pots but not the lid. While the theory of the genetically modified organism built in the laboratory is becoming more and more concrete on the origin of the SARS-2 virus, here is the second hitch for one of the leading companies in the production of vaccines, the AstraZeneca of Anglo-Swedish ownership but actually controlled by the same American and Zionist shareholders of the Weapons Lobby (as demonstrated in previous investigations).

The problem is looming huge for Europe which has already booked 400 million doses of the Oxford University vaccine, developed by the Jenner Institute, of which AstraZeneca has blocked clinical trials after a first very serious spinal cord infection (which could cause paralysis in the guinea pig. human) to which is added a second dramatic case…

Two people have fallen ill during the trials of AstraZeneca’s coronavirus vaccine in the UK, the company’s internal papers revealed, and a source said they had both suffered from the same serious neurological disorder.

The company published details of the trials on Saturday, after facing criticism over the lack of transparency surrounding the testing of the much-anticipated vaccine against the virus, which has so far infected more than 30.8 million people and caused over 958,000 fatalities worldwide.

The first participant of the British trials – which are being conducted in conjunction with Oxford University – fell ill after receiving one dose of the experimental vaccine in July.

AstraZeneca Vaccine Trials stopped for Mysterious Illness: May Lead Paralysis. Big Pharma Deal against Trump

The female volunteer was later diagnosed with transverse myelitis, a rare inflammatory disease that affects the spinal cord, causing weakness, sensory alterations, and autonomic nervous-system dysfunction. The company’s spokeswoman later told the media the volunteer had undiagnosed multiple sclerosis, and the trials resumed.


The second female recipient of the vaccine suffered complications after the follow-up dose in September. AstraZeneca didn’t confirm her diagnosis, but a source told the New York Times it was also transverse myelitis.

On September 6, trials of the drug were paused again, after the second woman felt ill, but they resumed in Britain, Brazil, India, and South Africa less than a week later. The US hasn’t yet green-lighted the continuation of the test, however.

WUHAN-GATES 16. Criminal Pharma for Vaccines in EU. Fraud, Doping and Suicide

AstraZeneca, which has administered its vaccine to some 18,000 people worldwide, said in internal documents that the two cases of the illness were “unlikely to be associated with the vaccine, or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine.” 

Transverse myelitis is a serious and rare disease, and its repeated cases among the participants of the trials may well see AstraZeneca losing its vaccine bid all together.

AstraZeneca’s vaccine uses a monkey adenovirus that shares a gene with the Covid-19 coronavirus. It’s an untested method of vaccine development, according to Kirill Dmitriev, CEO of the Russian Direct Investment Fund that bankrolled the Russian vaccine development.

COVID-19: Putin’s Vaccine challenges Big Pharma Lobby. Why it’s frightening for WHO

Unlike AstraZeneca’s jab, Russia’s Sputnik V, the world’s first registered vaccine, uses human adenoviruses as a vector – an extensively studied approach.

Earlier this month, respected British medical journal The Lancet published the Russian Ministry of Health’s Sputnik V study, showing the vaccine to be 100 percent effective, producing antibodies in all 76 participants of early-stage trials.

ATTENTION READERS
Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy so a clear comprehension of VT’s independent non-censored media is understood and given its proper place in the world of news, opinion and media.

All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VTRead Full Policy NoticeComment Policy

Read more

Latest News

Black passenger arrested in viral TikTok after not showing ID had active warrants, police say

A viral TikTok showing a Black man being aggressively pulled out of the passenger seat after refusing to show...

Caught: Fake scientists giving false COVID death rates, Italy at over 12 percent, US near 4% – Veterans Today

By Gordon Duff, Senior EditorSome areas of the country, the US, are having low COVID death rates, we don’t know why.Nobody talks about it...

US Sets COVID Infection Record; Deaths Near 224K

The U.S. coronavirus caseload...

New Rasmussen Poll Has Democrats Extremely Nervous: Trump’s Black Approval Nears Whopping 50%

A new survey found that President Donald Trump’s approval rating among likely black voters skyrocketed between Monday and Friday of this week. The results...

This Week in Leftist Violence and Intimidation Vol. 9

Protesters attacked police officers on both the East and West Coast this week. A protest in Boston saw Antifa members eat an animal heart...

More Articles Like This